Healthcare economist experts working on the Blue Cross Blue Shield antitrust case for the past decade have calculated a value for the settlement’s injunctive relief in excess of $17.3 billion over the first ten years of its implementation. In addition to a $2.8 billion monetary payment, the significant benefits of the settlement’s injunctive relief include […]
Recently, Becker’s Hospital Review published an article regarding the Provider Settlement. The article can be found here.
THE BLUE CROSS BLUE SHIELD PROVIDER SETTLEMENT: AN UNBIASED OPINION Read More »
If you or your business provided healthcare services, equipment, or supplies to Blue Plan patients anytime from July 24, 2008, to October 4, 2024, you may be eligible to submit a claim for your share of a $2.8 billion settlement reached with the Blue Cross and Blue Shield system. The settlement, reached earlier this year
Jeffrey Gold, Special Counsel of the Managed Care and Insurance division at the Healthcare Association of New York State (HANYS) recently shared his insights on the risks of opting out of the Blue Cross Blue Shield Provider Antitrust Litigation. His blog post can be found here.
JEFFREY GOLD – THE RISKS OF OPTING OUT OF THE LANDMARK BCBS ANTITRUST SETTLEMENT Read More »
BIRMINGHAM, Ala., Dec. 16, 2024 /PRNewswire/ — Whatley Kallas, LLP Announces Major Settlement for Healthcare Providers A landmark $2.8 billion settlement has been reached with the Blue Cross Blue Shield Association (“BCBSA”) and participating Individual Blue Plans (“Settling Defendants”). The settlement resolves claims brought by healthcare providers alleging anti-competitive practices, including agreements to divide geographic service areas and price-fixing for
Jeffrey Gold, Special Counsel of the Managed Care and Insurance division at the Healthcare Association of New York State (HANYS) recently shared his insights on how the Blue Cross Blue Shield Provider Antitrust Litigation will transform the BlueCard program for providers. His blog post can be found here.
FOR IMMEDIATE RELEASE: December 6, 2024 BIRMINGHAM, AL – Whatley Kallas, LLP—Co-Lead Counsel in the long-running antitrust lawsuit filed on behalf of healthcare providers nationwide— has announced a significant milestone in the case: the Court has granted preliminary approval of the settlement. The monumental settlement involving all Blue Cross and Blue Shield entities and the
The court overseeing the Blue Cross Blue Shield Antitrust Litigation has granted preliminary approval of the Provider Plaintiffs’ settlement, which provides $2.8 billion in monetary relief and extensive injunctive relief to healthcare providers. A copy of the preliminary approval order can be found here, and on Whatley Kallas’s settlement website at www.whatleykallas.com/bcbs-settlement.
COURT PRELIMINARILY APPROVES BLUE CROSS BLUE SHIELD SETTLEMENT Read More »
The Centers for Medicare & Medicaid Services has published rules governing Medicare Advantage for the 2026 contract year, which would add significant protections for enrollees and providers. Among the most significant provisions, the rules would: Tighten prior authorization requirements “to remove unnecessary barriers to care stemming from the use of inappropriate prior authorization” by adding
CMS PROPOSES RULES ADDING SIGNIFICANT PROTECTIONS TO THE MEDICARE ADVANTAGE PROGRAM Read More »
Judge Proctor has set the Preliminary Approval Hearing on the Provider Settlement in the Blue Cross Blue Shield Antitrust Litigation for November 14, 2024, at 9:30 a.m. in Birmingham, Alabama. A copy of Judge Proctor’s Order can be found here. Up to date information on the settlement may also be found at www.whatleykallas.com/bcbs-settlement.